Antiviral activity of immunomodulator Selank in experimental influenza infection


Cite item

Full Text

Abstract

The main objective of this study was to evaluate the antiviral properties of the glyproline Selank in both in vitro and in vivo against the influenza virus strain A/Aichi 2/68 (H3N2). The pronounced antiviral effect of the agent was detected in both systems. Selank added to the cell culture 24 hours before inoculation (a preventive use scheme) showed the highest efficiency, by completely suppressing viral reproduction. The in vivo studies also demonstrated that the highest survival of laboratory animals was observed when the agent was administered by the prevention scheme. The use of Selank in vivo induced the gene expression of interferon-б (IFN-б), without affecting that of interleukin (IL)-4, IL-10, or tumor necrosis factor-б (TNF-б). The findings suggest that the mechanism of the antiviral action of Selank may be due to its ability to modulate Th1/Th2/Treg cytokine equilibrium both directly and indirectly via the central nervous system. This is particularly promising if that the agent is synthesized on the basis of an endogenous peptide and that it has no negative effects is kept in mind.

References

  1. Ашмарин И. П. Предполагаемые и непредвиденные физиологические эффекты олигопептидов (глипролинов, аналогов АКТГ(4-10), тафтцина и тиролиберина) // Рос. физиол. журн. - 2001. Т. 87, № 11. - С. 1471-1476.
  2. Гумен А. В., Шанин С. Н., Козинец И. А. и др. Цитотоксическая активность натуральных киллерных клеток селезенки крыс при стрессе и ее коррекция короткими иммуномодулирующими пептидами // Цитокины и воспаление. - 2006. - Т. 5, № 2. - С. 37-41.
  3. Ершов Ф. И. Система интерферона в норме и при патологии. - М.; 1996.
  4. Ершов Ф. И. Интерфероны (к 40-летию открытия). Обзор //Вопр. вирусол. - 1998. - Т. 43, № 6. - С. 247-252.
  5. Учакина О. Н., Учакин П. Н., Мезенцева М. В. и др. Цитокиновый баланс при болезнях Паркинсона и Вильсона-Коновалова // Цитокины и воспаление. - 2008. Т. 6, № 3. - С. 63-68.
  6. Шубладзе А. К., Гайдамович С. Я. Краткий курс практической вирусологии. - М.; Медгиз, 1964.
  7. Bot A., Holz A., Christen U., Wolfe T. et al. Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic Т cell responses // Virology. - 2000. - Vol. 269, N 1. - P. 66-77.
  8. Fridkin M., Najjar V. A. Tuftsin: its chemistry, biology, and clinical potential // Crit. Rev. Biochem. Mol. Biol. - 1989. - Vol. 24, N . P. 1-40.
  9. Levy D. E., Garsia-Sastre A. The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion // Cytokine Growth Factor Rev. - 2001. - Vol. 12. - 143-156.
  10. Maniatis Т., Fritsch E. F., Sambrook J. Molecular cloning. A laboratory manual. - New York; 1982.
  11. Price G. E., Gaszewska-Mastarlarz A., Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice // J. Virol. - 2000. - Vol. 74, N 9. - P. 3996-4003.
  12. Stabinsky Y., Gottlieb P., Zakuth V. et al. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes // Biochem. Biophys. Res. Commun. - 1978. - Vol. 83, N 2. - 599-606.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Ershov F.I., Uchakin P.N., Uchakina O.N., Mezentseva M.V., Alekseyeva L.A., Myasoyedov N.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies